Cargando…
Interchangeability for Biologics is a Legal Distinction in the USA, Not a Clinical One
Biologics are increasingly vital medicines that significantly reduce morbidity as well as mortality, yet access continues to be an issue even in apparently wealthy countries, such as the USA. While patient access is expected to improve with the introduction of biosimilars, misperceptions in a signif...
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer International Publishing
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9190447/ https://www.ncbi.nlm.nih.gov/pubmed/35696067 http://dx.doi.org/10.1007/s40259-022-00538-6 |